‹ GH latest research

GH (Guardant Health, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed GH on 10 market nights between May 25, 2026 and October 8, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

10 calls 5 BUY · 4 HOLD · 1 SELL BUY calls up after 20 trading days: 4 of 5
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 8, 2026 HOLD $168.33 — / — not yet not yet
The current market regime and the stock's risk profile necessitate a cautious approach, making a short-term outlook appropriate for potential re-evaluation.
October 7, 2026 HOLD $170.69 — / — not yet not yet
The current setup does not warrant a trade.
September 21, 2026 HOLD $179.38 $206.28 / $152.47 +2.0% not yet
The stock is near a 52-week high with mixed technical signals, suggesting a short-term trading opportunity rather than a long-term investment.
September 16, 2026 HOLD $175.65 — / — +0.8% not yet
The trade is not being initiated due to mandatory rule violation.
July 29, 2026 BUY $143.62 — / — +13.3% +18.6%
The current market regime and the stock's technical and risk profile do not support a buy recommendation.
July 21, 2026 BUY $148.07 — / — -5.7% +5.1%
Continued progress and potential positive news regarding the Shield test's insurance coverage.
July 1, 2026 BUY $150.03 — / — -3.9% -10.8%
Insider buying from an executive or director.
May 28, 2026 BUY $127.51 $153.60 / $108.80 -0.1% +12.0%
The post-earnings drift signal suggests a sustained upward move over the coming weeks.
May 26, 2026 SELL $118.95 — / — +8.6% +14.3%
The post-earnings drift is still playing out, but significant risks and a neutral market regime warrant caution.
May 25, 2026 BUY $118.95 $138.60 / $98.18 +8.6% +14.3%
The post-earnings drift pattern suggests a sustained upward move over several weeks.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.